SEC Form 4 · accession 0001493152-16-015646
Enhance Skin Products Inc · EHSK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel Asculai
Officer — Chief Scientific Officer · Director · 10% Owner
Period of report
Dec 2, 2016
Accepted (ET)
Dec 5, 2016 · 10:18 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001395400
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Dec 2, 2016 | J | 16,333,333 | $0.0018 | A | 52,978,044 | D | |
| Common SharesF2 | Dec 2, 2016 | J | 4,225,606 | $0.0101 | A | 52,978,044 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issued in conversion of debt of $29,400 for services previously rendered under a Consultancy Agreement at dated March 5, 2013 as amended March 3, 2014, August 1, 2015, March 21, 2016, and October 1, 2016 (the "Asculai Consultancy Agreement").
- F2Shares issued in conversion of debt of $42,969 for services previously rendered under the Asculai Consultancy Agreement.